Eastman Kodak Co. (KODK) Jumps 6.06% on January 29

Equities Staff |

Eastman Kodak Co. (KODK) was among the biggest gainers on the Russell 2000 for Friday January 29 as the stock popped 6.06% to $9.10, representing a gain of $0.52 per share. Some 95,193 shares traded hands on 862 trades, compared with an average daily volume of 185,630 shares out of a total float of 41.99 million. The stock opened at $8.59 and traded with an intraday range of $9.14 to $8.59.

After today's gains, Eastman Kodak Co. reached a market cap of $382.12 million. Eastman Kodak Co. has had a trading range between $20.97 and $7.56 over the last year, and it had a 50-day SMA of $11.71 and a 200-day SMA of $15.14.

Eastman Kodak Co is a technology company providing imaging for business. It provides commercial products and services in technologies including materials science; digital imaging science and software; and deposition processes.

Eastman Kodak Co. is based out of Rochester, NY and has some 7,300 employees. Its CEO is Jeffrey J. Clarke.

For a complete fundamental analysis analysis of Eastman Kodak Co., check out Equities.com’s Stock Valuation Analysis report for KODK. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets

Santo Diablo Mezcal

Santo Diablo Mezcal has been created to capitalize on a boom sector of the beverage market currently full of many small unmemorable products by producing one sexy, household, easily recognizable…


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…